Actavis – pharmaceutical daily

March 1, 2017 Off

Orexo AB files patent violation against Teva’s Actavis in US

Another patent infringement against Teva has been filed in recent couple of months. Orexo AB has filed a patent infringement action in United States District Court for the District of Delaware against Actavis Elizabeth LLC, Actavis Pharma, Inc., and their parent company Teva.

January 21, 2016 Off

Glenmark Pharmaceuticals entering $130M market with two new generic medicines

By Dino Mustafić

Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets

November 25, 2015 Off

Allergan settles with New York over Memantine. Agrees to pay $170K for state’s litigation expenses

By Dino Mustafić

Allergan has agreed with the New York State Attorney General’s Office to end the litigation under Section 2 of the Sherman Act, and other statutes with the Attorney General over the decision of Forest Laboratories